Contraception

Birth control authority grows to pharmacists

June 16, 2021

An increasing number of pharmacists are now prescribing birth control, further expanding their role as public health service providers.

Progestogen-only pill for emergency contraception

June 15, 2021

The authors of the prospective study in the journal Health Technology Assessment believe the simple intervention has enormous potential to prevent more unintended pregnancies after emergency contraception.

ACOG 2021: Beyond the Pandemic

June 10, 2021

Significant updates occurred in women’s health issues while the world was in survival mode.

Gauging a transdermal contraceptive system by BMI

May 19, 2021

The new analysis, which was presented virtually at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting, concludes that the TDS maintained similar safety and tolerability in the 2 groups of women.

Efficacy of emergency oral contraception

May 18, 2021

Contrary to popular belief, emergency oral contraception is not that effective.

Contraception for women with cardiovascular disease

April 21, 2021

Early and routine contraceptive counseling for all women of reproductive age with cardiovascular disease or cardiovascular risk factors is an essential component of comprehensive cardiovascular care, according to evidence-based recommendations of contraceptive options published in the Journal of the American College of Cardiology (JACC).

Contraception before and after diabetes diagnosis

April 20, 2021

Women with diabetes are slightly less likely to use contraception after their diabetes diagnosis, according to a retrospective cohort study in the journal Primary Care Diabetes.

FDA Approves New Oral Contraceptive Nextstellis

April 16, 2021

Nextstellis (drospirenone; estetrol) now is approved as a combined oral contraceptive for birth control.

S3E5: LARC in the time of COVID-19 and telehealth: Part 2

April 07, 2021

This video interview features Rachael Phelps, MD, Medical Director at Planned Parenthood of Central and Western New York, and of the Rochester LARC Initiative; and Amber Truehart, MD, Assistant Professor of Obstetrics and Gynecology, Section of Family Planning and Contraceptive Research at the University of Chicago.

Oral contraceptive and ovarian function

April 06, 2021

A prospective study to assess the effects of an oral contraceptive containing estetrol and drospirenone on ovarian function found treatment achieved complete ovulation inhibition.